Advertisement
Screener

HeartSciences Inc. (HSCS) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

HeartSciences Inc. Research and Development Expense

HeartSciences Inc. (HSCS) reported Research and Development Expense of $906.63 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-14

  • HeartSciences Inc. research and development expense for the quarter ending 2026-07-31 was $906.63K, a 9.08% decline year-over-year.
  • HeartSciences Inc. research and development expense for the quarter ending 2026-04-30 was $476.20K, a 48.75% decline year-over-year.
  • HeartSciences Inc. research and development expense for the quarter ending 2026-01-31 was $638.58K, a 38.19% decline year-over-year.
  • HeartSciences Inc. research and development expense for the quarter ending 2025-10-31 was $727.03K, a 39.36% decline year-over-year.
  • HeartSciences Inc. research and development expense for fiscal 2026 was $2.84M, a 35.27% decline from fiscal 2025.
  • HeartSciences Inc. research and development expense for fiscal 2025 was $4.39M, a 52.37% increase from fiscal 2024.
  • HeartSciences Inc. research and development expense for fiscal 2024 was $2.88M, a 16.97% increase from fiscal 2023.
  • HeartSciences Inc. research and development expense for fiscal 2023 was $2.46M, a 18.01% decline from fiscal 2022.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2026-07-31$906.63K
10-Q · filed 2026-09-14
$1.38M
derived: sum of 2 quarters · filed 2026-09-14
$2.02M
derived: sum of 3 quarters · filed 2026-09-14
$2.75M
derived: sum of 4 quarters · filed 2026-09-14
2026-04-30$476.20K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-23
$1.11M
derived: sum of 2 quarters · filed 2026-07-23
$1.84M
derived: sum of 3 quarters · filed 2026-07-23
$2.84M
10-K · filed 2026-07-23
2026-01-31$638.58K
10-Q · filed 2026-03-16
$1.37M
derived: sum of 2 quarters · filed 2026-03-16
$2.36M
10-Q · filed 2026-03-16
$3.29M
derived: sum of 4 quarters · filed 2026-09-14
2025-10-31$727.03K
10-Q · filed 2025-12-15
$1.72M
10-Q · filed 2025-12-15
$2.65M
derived: sum of 3 quarters · filed 2026-09-14
$3.69M
derived: sum of 4 quarters · filed 2026-09-14
2025-07-31$997.21K
10-Q · filed 2026-09-14
$1.93M
derived: sum of 2 quarters · filed 2026-09-14
$2.96M
derived: sum of 3 quarters · filed 2026-09-14
$4.16M
derived: sum of 4 quarters · filed 2026-09-14
2025-04-30$929.09K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-23
$1.96M
derived: sum of 2 quarters · filed 2026-07-23
$3.16M
derived: sum of 3 quarters · filed 2026-07-23
$4.39M
10-K · filed 2026-07-23
2025-01-31$1.03M
10-Q · filed 2026-03-16
$2.23M
derived: sum of 2 quarters · filed 2026-03-16
$3.46M
10-Q · filed 2026-03-16
$4.50M
derived: sum of 4 quarters · filed 2026-03-16
2024-10-31$1.20M
10-Q · filed 2025-12-15
$2.42M
10-Q · filed 2025-12-15
$3.47M
derived: sum of 3 quarters · filed 2025-12-15
$3.98M
derived: sum of 4 quarters · filed 2025-12-15
2024-07-31$1.22M
10-Q · filed 2025-09-11
$2.27M
derived: sum of 2 quarters · filed 2025-09-11
$2.78M
derived: sum of 3 quarters · filed 2025-09-11
$3.54M
derived: sum of 4 quarters · filed 2025-09-11
2024-04-30$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24
$1.56M
derived: sum of 2 quarters · filed 2025-07-24
$2.31M
derived: sum of 3 quarters · filed 2025-07-24
$2.88M
10-K · filed 2025-07-24
2024-01-31$509.51K
10-Q · filed 2025-03-13
$1.27M
derived: sum of 2 quarters · filed 2025-03-13
$1.83M
10-Q · filed 2025-03-13
$2.37M
derived: sum of 4 quarters · filed 2025-03-13
2023-10-31$757.30K
10-Q · filed 2024-12-16
$1.32M
10-Q · filed 2024-12-16
$1.86M
derived: sum of 3 quarters · filed 2024-12-16
$2.50M
derived: sum of 4 quarters · filed 2024-12-16
2023-07-31$565.63K
10-Q · filed 2024-09-12
$1.10M
derived: sum of 2 quarters · filed 2024-09-12
$1.74M
derived: sum of 3 quarters · filed 2024-09-12
$2.59M
derived: sum of 4 quarters · filed 2024-09-12
2023-04-30$534.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-29
$1.18M
derived: sum of 2 quarters · filed 2024-07-29
$2.03M
derived: sum of 3 quarters · filed 2024-07-29
$2.46M
10-K · filed 2024-07-29
2023-01-31$643.26K
10-Q · filed 2024-03-14
$1.49M
derived: sum of 2 quarters · filed 2024-03-14
$1.93M
10-Q · filed 2024-03-14
$3.28M
derived: sum of 4 quarters · filed 2024-03-14
2022-10-31$848.98K
10-Q · filed 2023-12-14
$1.28M
10-Q · filed 2023-12-14
$2.64M
derived: sum of 3 quarters · filed 2023-12-14
$3.34M
derived: sum of 4 quarters · filed 2023-12-14
2022-07-31$434.20K
10-Q · filed 2023-09-14
$1.79M
derived: sum of 2 quarters · filed 2023-09-14
$2.49M
derived: sum of 3 quarters · filed 2023-09-14
$3.03M
derived: sum of 4 quarters · filed 2023-09-14
2022-04-30$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-19
$2.05M
derived: sum of 2 quarters · filed 2023-07-19
$2.60M
derived: sum of 3 quarters · filed 2023-07-19
$3.00M
10-K · filed 2023-07-19
2022-01-31$699.01K
10-Q · filed 2023-03-16
$1.24M
derived: sum of 2 quarters · filed 2023-03-16
$1.65M
10-Q · filed 2023-03-16
2021-10-31$545.77K
10-Q · filed 2022-12-15
$946.89K
10-Q · filed 2022-12-15
2021-07-31$401.11K
10-Q · filed 2022-09-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
DarkHorse Technologies Inc. (ANY)$0.025B
Binah Capital Group, Inc. (BCG)United States$0.020B6.21
Pineapple Financial Inc. (PAPL)Canada$0.026B
AIxCrypto Holdings, Inc. (AIXC)United States$0.029B-1.02
AtlasClear Holdings, Inc. (ATCH)United States$0.030B
MDB Capital Holdings, LLC (MDBH)United States$0.016B
Fold Holdings, Inc. (FLD)United States$0.030B
VerifyMe, Inc. (VRME)United States$0.015B-1.55
House of Doge Inc. (HODO)United States$0.015B
TAO Synergies Inc. (TAOX)United States$0.033B